Vutrisiran Shows Sustained Benefits in Cardiac Amyloidosis ...Middle East

Vutrisiran can improve and maintain functional capacity and quality of life in patients with transthyretin amyloidosis with cardiomyopathy, according to a follow-up analysis of data from the HELIOS-B trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Vutrisiran Shows Sustained Benefits in Cardiac Amyloidosis )

Also on site :

• Baby food recalled over lead contamination fears
• Asian shares fall after a quiet day on Wall St, but Nvidia hit by US ban on exporting AI chip
• Defying courts in deportation case, Trump risks a tipping point, experts say